On June 21, 2018, Peking University Medical Department and Mei Nian Health Industry Holding Co., Ltd. (referred to as the “Ministry of Healthâ€) jointly announced at the “First Health Zhigu Summit Forum†held in Shenzhen that the two sides cooperated to establish the “Peking University Medical Department Beautyâ€. The Public Health Research Institute aims to build a world-class public health and big data research and practice platform based on data sharing and research results. The Arterial Network has learned that the Beiyi Mei Nian Public Health Research Institute will include four aspects of functional positioning: sharing scientific research projects in the national health field, conducting health big data mining analysis, publishing a blue book of health, and standardizing technical guidance and support for medical examination standards. The two sides intend to establish an ethics committee and an expert committee to be responsible for the evaluation of scientific research projects in the national health field and for the review of applications for biological specimens and medical examination data. In addition, Peking University Medical Department and Mei Nian Health will also build a new mode of medical cooperation - joint practice on public health and preventive medicine, health management and disease management, translational medicine and industrial development, evidence-based medicine and evidence-based decision-making. And communication. Peking University School of Medicine is one of the most important medical innovation research bases in China and a medium for advanced medical and health personnel. It is also the first batch of institutions of higher education in the national “211 Project†and “985 Projectâ€, covering basic medicine, clinical medicine, preventive medicine. Six major categories, including stomatology, pharmacy, and nursing, integrate teaching, scientific research, and medical care . As the world's largest personal health big data platform and preventive medicine platform, Mei Nian Health is also one of the highest value-added medical service companies in China. It has more than 400 medical and physical examination centers in more than 200 core cities across the country. In 2017, the company has 2000. More than 10,000 people provide professional health services, and it is expected to serve more than 100 million people in 2021. Signing Ceremony for the Establishment of the "Public Health Research Institute of Peking University Medical School" At the signing ceremony, Zhan Qimin, an academician of the Chinese Academy of Engineering, executive vice president of Peking University, and director of the Peking University Medical Department, pointed out that “healthy medical big data is an important basic strategic resource of the country and has become a hot spot for industry development. The biological sample database is an important support platform. With the biological sample resources, whoever masters the initiative of medical science and technology, who can occupy the commanding heights of medical competition. In his view, in the future, precision medicine should go through the whole process of diseases including disease risk prediction, diagnosis and classification, drug application, efficacy evaluation, and prognosis prediction. Accurate medicine requires cutting-edge multidisciplinary integration, and scientific and technological innovations in the fields of diagnosis, treatment and big data analysis need to achieve rapid cornering overtaking. Integrative medicine and translational medicine are only the modes and mechanisms of medical development. Precision medicine is the goal and requirement of medical development. It is an important connotation and goal of translational medicine research, and it is a new historical requirement of evidence-based medicine. The main battlefield for the development of precision medicine in the community and hospitals requires large samples and big data support, and more needs the joint efforts of government, industry, and research. Zhan Qimin, Academician of the Chinese Academy of Engineering, Executive Vice President of Peking University, and Director of the Department of Medicine, Peking University Li Liming, professor of Peking University School of Public Health, honorary academician of the Royal College of Public Health, and academician of the International Eurasian Academy of Sciences, said that the rapid development of genomics technology, the advancement of biomedical analysis technology, and the emergence of big data analysis tools have promoted our precision. The arrival of the medical age. As an important part of health management, precision prevention is not only about disease diagnosis and classification treatment strategies, but also about disease risk diagnosis and prevention strategies, which benefit the wider population, delay and reduce the occurrence of diseases. The development of precise prevention is the refinement of health management. The combination of health management and disease management can realize the health care service of life cycle, and take the community as the combination point to finally realize the grand goal of healthy China. "The United States and the United States are the leaders of China's health management industry. They are large-scale, wide-ranging and strong. They are China's largest personal health check-up big data platform. In the future, we will carry out six major aspects, health management and disease. Theoretical and practical research on management, chronic disease health influencing factors and predictive early warning research, systematic epidemiological research and precision prevention research, data science and big data mining based on human population testing and follow-up, technical evidence research, evidence-based health decision-making and translational medical research And the research on health human resources training and policy development, these six aspects are developed around the strategic technology reserve of precision medicine , big data and artificial intelligence." Li Liming pointed out. Li Liming, Professor, School of Public Health, Peking University, Honorary Fellow of the Royal College of Public Health, and Fellow of the International Eurasian Academy of Sciences Yu Rong, Chairman of Mei Nian Health, pointed out that the cooperation between the US Health and the Peking University Medical Department has opened a new chapter in the research and development of public health big data in China's medical and health industry. The two sides will join hands and will be in the field of professional medical science and public health. In-depth exchanges and cooperation with the field of social practice. Yu Rong further pointed out that no era can give such important development opportunities to the medical and health industry. "Our existing scenarios are very conducive to achieving industry innovation and technological breakthroughs, because we have several elements, the first is the scene, and the second is Traffic, the third is technology, and the fourth is talent. As the world's largest personal health and preventive medicine flow portal, Mei Nian Health has the inherent advantages of traffic and scenes. In terms of technology and talents, the United States, with the support of the national ministries, is in the entrepreneurial hotspot of Shenzhen, especially Yantian. Such a carrier with strong life health and genes, with the resources of health Zhigu and the ability to allocate systematic resources, form a rare combination of traffic, data, scenes and talents, and the future will be fruitful. Some key areas that present epic innovations." All along, Mei Nian Health is committed to providing professional and high-quality medical examination services, following the business logic of “Professional Medical Examination - Accurate Data - High Risk Screening - Risk Assessment - Health Management", the health of the United States is "flow + technology + ecosystem "Advantages, focus on building a large health industry cluster with the most potential for development in China, and strive to become a data-driven & unlimited life technology and health service company. Yu Rongmei Nian Health Chairman After the signing ceremony, the "Zhongguancun Mei Nian Health Industry Research Institute Academician Studio - Shenzhen Branch" was officially unveiled, aiming to integrate the experts in the medical field and conduct in-depth cooperation with experts in various disease specialist fields to promote the industrialization of medical research results. Dr. Ning Yi, Executive Dean of Zhongguancun Mei Nian Health Industry Research Institute, was officially hired as an adjunct professor of Peking University Medical School. Academician of the Chinese Academy of Engineering, Executive Vice President of Peking University, and Academician Zhan Qimin of Peking University Medical Department issued an appointment letter. On the same day, the “Seventh China Innovation and Entrepreneurship Competition for Large and Medium-sized Enterprises†(the US-year health special event) was officially launched. The event focused on the direction of intelligent precision medical technology and focused on the application of big data and artificial intelligence technology in precision medicine. The competition is divided into the start-up enterprise group and the growth enterprise group. Through the open competition, the project value is found. The health of the company will rely on its own technology, platform, capital, market and other innovative and entrepreneurial resources to connect with the participating enterprises on an equal footing, promote collaborative innovation and entrepreneurship, and integrate development. The special game by the Yantian District of Shenzhen Municipal People's Government support, co-hosted by the United States of Health and Beijing Wandong Medical Technology Co., Ltd. and Shenzhen Health Intelligence Valley.
Organic maltodextrin is a white powder made from corn starch through enzymatic hydrolysis. It is often used as a food additive. It is easy to digest, absorbs as fast as glucose, and is moderately sweet or almost tasteless.
We provide various specifications of organic maltodextrin to meet a wide range of customer needs such as thickeners, fixatives, and puffed foods. Organic maltodextrin is widely used in beverages, frozen foods, candies, cereals, dairy products, health products, etc. It can also be used in daily chemical and pharmaceutical production.
Our organic corn farm is located in northeast China, with a suitable climate and fertile soil, which can ensure the quality of corn. Therefore, the quality of our corn starch and maltodextrin are industry-leading. At the same time, we can also issue EU and USDA organic certificates for customers to prove the source of maltodextrin.
Organic Maltodextrin Powder,Maltodextrin Powder,Corn Maltodextrin,Corn Maltodextrin Organic Organicway (xi'an) Food Ingredients Inc. , https://www.organicwayince.com
